AAAAAA

   
Results: 1-22 |
Results: 22
RB AND P16 EXPRESSION IN NONSMALL CELL LUNG-CANCER (NSCLC)
Authors: FLIEDER DB BRAMBILLA E RUSH W PRZYGODZKI R FLEMING M FREEDMAN A TRAVIS W CAPORASO N GUINEE D BENNETT W JONES R TRASTEK V PAIROLERO P TAZELAAR H JETT J MIDTHUN D LIOTTA L HARRIS CC
Citation: Db. Flieder et al., RB AND P16 EXPRESSION IN NONSMALL CELL LUNG-CANCER (NSCLC), Modern pathology, 11(1), 1998, pp. 173-173
KI.67 STAINING (KI.67-PERCENT), A PREDICTOR OF SURVIVAL AND PERFORMANCE STATUS, IS ASSOCIATED WITH APOPTOSIS, NECROSIS, GRADE, HISTOLOGY, AND SMOKING IN NONSMALL CELL LUNG CARCINOMAS (NSCC)
Authors: FLEMING M CAPORASO N ROSS W BENNETT W TRAVIS W MIDTHUN D JETT J TAZELAAR H TRASTEK V PAIROLERO P LIOTTA L HARRIS C
Citation: M. Fleming et al., KI.67 STAINING (KI.67-PERCENT), A PREDICTOR OF SURVIVAL AND PERFORMANCE STATUS, IS ASSOCIATED WITH APOPTOSIS, NECROSIS, GRADE, HISTOLOGY, AND SMOKING IN NONSMALL CELL LUNG CARCINOMAS (NSCC), Modern pathology, 11(1), 1998, pp. 173-173
TRANSFORMING-GROWTH-FACTOR-BETA RECEPTOR-TYPE-II EXPRESSION IN NONSMALL CELL LUNG CARCINOMAS
Authors: RUSH W CAPORASO N FREEDMAN A BENNETT W FLEMING M MIDTHUN D TAZELAAR H PAIROLERO P TRASTEK V LIOTTA L HARRIS C TRAVIS W
Citation: W. Rush et al., TRANSFORMING-GROWTH-FACTOR-BETA RECEPTOR-TYPE-II EXPRESSION IN NONSMALL CELL LUNG CARCINOMAS, Modern pathology, 11(1), 1998, pp. 179-179
POSTTRANSPLANTATION SURVIVAL OF PATIENTS WITH IDIOPATHIC GIANT-CELL MYOCARDITIS (GCM) VERSUS CARDIOMYOPATHY (CM)
Authors: COOPER LT OLSON LJ BERRY GJ TAZELAAR H
Citation: Lt. Cooper et al., POSTTRANSPLANTATION SURVIVAL OF PATIENTS WITH IDIOPATHIC GIANT-CELL MYOCARDITIS (GCM) VERSUS CARDIOMYOPATHY (CM), Journal of the American College of Cardiology, 31(2), 1998, pp. 251-251
BCL-2 IMMUNOHISTOCHEMISTRY IN A SURGICAL SERIES OF NONSMALL CELL LUNG-CANCER PATIENTS
Authors: FLEMING MV GUINEE DG CHU WS FREEDMAN AN CAPORASO NE BENNETT WP COLBY TV TAZELAAR H ABBONDANZO SL JETT J PAIROLERO P TRASTEK V LIOTTA LA HARRIS CC TRAVIS WD
Citation: Mv. Fleming et al., BCL-2 IMMUNOHISTOCHEMISTRY IN A SURGICAL SERIES OF NONSMALL CELL LUNG-CANCER PATIENTS, Human pathology, 29(1), 1998, pp. 60-64
INCREASED LEVELS OF CIRCULATING NITRATES AND IMPAIRED ENDOTHELIUM-MEDIATED VASODILATION SUGGEST MULTIPLE ROLES OF NITRIC-OXIDE DURING ACUTEREJECTION OF PULMONARY ALLOGRAFTS
Authors: WIKLUND L LEWIS DH SJOQUIST PO NILSSON F TAZELAAR H MILLER VM MCGREGOR CGA
Citation: L. Wiklund et al., INCREASED LEVELS OF CIRCULATING NITRATES AND IMPAIRED ENDOTHELIUM-MEDIATED VASODILATION SUGGEST MULTIPLE ROLES OF NITRIC-OXIDE DURING ACUTEREJECTION OF PULMONARY ALLOGRAFTS, The Journal of heart and lung transplantation, 16(5), 1997, pp. 517-523
TREATMENT WITH AN ANTIOXIDANT INHIBITS VASCULAR CHANGES CAUSED BY CIRCULATING LYMPHOCYTES DURING ACUTE LUNG REJECTION IN DOGS
Authors: WIKLUND L NILSSON F SCHERSTEN H SJOQUIST PO TAZELAAR H MILLER VM MCGREGOR CGA
Citation: L. Wiklund et al., TREATMENT WITH AN ANTIOXIDANT INHIBITS VASCULAR CHANGES CAUSED BY CIRCULATING LYMPHOCYTES DURING ACUTE LUNG REJECTION IN DOGS, Transplantation, 64(6), 1997, pp. 807-811
CYCLIN D1, P53 AND P21(WAF1 CIP1) EXPRESSION PREDICT SURVIVAL IN NONSMALL CELL LUNG-CANCER (NSCLC)/
Authors: BURKE L FREEDMAN A ELDEIRY W BENNETT W GUINEE D RUSH W PRZYGODZKI R JONES R BORKOWSKI A CAPORASO N FLEMING MV TRAVIS W COLBY T TRASTEK V PAIROLERO P TAZELAAR H MIDTHUN D LIOTTA L VOGELSTEIN B HARRIS C
Citation: L. Burke et al., CYCLIN D1, P53 AND P21(WAF1 CIP1) EXPRESSION PREDICT SURVIVAL IN NONSMALL CELL LUNG-CANCER (NSCLC)/, Laboratory investigation, 76(1), 1997, pp. 946-946
BAX IMMUNOHISTOCHEMICAL STAINING (IHC) RELATES TO GENDER, GRADE, HISTOLOGY, FAMILY HISTORY, AND K-RAS MUTATIONS IN NONSMALL CELL CARCINOMAS(NSCC) OF THE LUNG
Authors: FLEMING M BRAMBILLA E FREEDMAN A PRZYGODZKI R CAPORASO N BENNETT W TRAVIS W COLBY T JETT J TAZELAAR H TRASTEK V PAIROLERO P LIOTTA L HARRIS C
Citation: M. Fleming et al., BAX IMMUNOHISTOCHEMICAL STAINING (IHC) RELATES TO GENDER, GRADE, HISTOLOGY, FAMILY HISTORY, AND K-RAS MUTATIONS IN NONSMALL CELL CARCINOMAS(NSCC) OF THE LUNG, Laboratory investigation, 76(1), 1997, pp. 960-960
HIGHER RATE OF ALPHA-1-ANTITRYPSIN (ALPHA-1AT) DEFICIENCY CARRIERS FOUND IN LUNG-CANCER PATIENTS
Authors: YANG P WENTZLAFF KA MARKS R PATEL A ALLEN M EDELL E KATZMANN J LESNICK T DESCHAMPS C MIDTHUN D BONNER J SWENSEN S TAZELAAR H KROWKA MJ
Citation: P. Yang et al., HIGHER RATE OF ALPHA-1-ANTITRYPSIN (ALPHA-1AT) DEFICIENCY CARRIERS FOUND IN LUNG-CANCER PATIENTS, American journal of human genetics, 61(4), 1997, pp. 72-72
ANTI-P53 ANTIBODIES IN SERA FROM PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY-DISEASE CAN PREDATE A DIAGNOSIS OF CANCER
Authors: TRIVERS GE DEBENEDETTI VMG CAWLEY HL CARON G HARRINGTON AM BENNETT WP JETT JR COLBY TV TAZELAAR H PAIROLERO P MILLER RD HARRIS CC
Citation: Ge. Trivers et al., ANTI-P53 ANTIBODIES IN SERA FROM PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY-DISEASE CAN PREDATE A DIAGNOSIS OF CANCER, Clinical cancer research, 2(10), 1996, pp. 1767-1775
P53 MUTATIONS AND OCCUPATIONAL EXPOSURES IN A SURGICAL SERIES OF LUNGCANCERS
Authors: HARTY LC GUINEE DG TRAVIS WD BENNETT WP JETT J COLBY TV TAZELAAR H TRASTEK V PAIROLERO P LIOTTA LA HARRIS CC CAPORASO NE
Citation: Lc. Harty et al., P53 MUTATIONS AND OCCUPATIONAL EXPOSURES IN A SURGICAL SERIES OF LUNGCANCERS, Cancer epidemiology, biomarkers & prevention, 5(12), 1996, pp. 997-1003
GENDER, AGE, AND ENVIRONMENTAL EXPOSURES ARE ASSOCIATED WITH INCREASED APOPTOSIS IN NON-SMALL-CELL (NSC) LUNG CARCINOMAS
Authors: FLEMING MV FALK R PRZYGODZKI R ZHANG J BENNETT WP TRAVIS WD COLBY TV JETT J TAZELAAR H TRASTEK V PAIROLERO P LIOTTA LA CAPORASO NE FERRANS VJ HARRIS CC
Citation: Mv. Fleming et al., GENDER, AGE, AND ENVIRONMENTAL EXPOSURES ARE ASSOCIATED WITH INCREASED APOPTOSIS IN NON-SMALL-CELL (NSC) LUNG CARCINOMAS, Laboratory investigation, 74(1), 1996, pp. 904-904
K-RAS-2 MUTATIONS IN SUBJECTS WITH LUNG-CARCINOMA IN THE NCI-MAYO LUNG-CANCER STUDY
Authors: PRZYGODZKI RM CAPORASO NE BENNETT WP TRAVIS WD COLBY TV JETT J TAZELAAR H PAIROLERO P TRASTEK V LIOTTA LA HARRIS CC
Citation: Rm. Przygodzki et al., K-RAS-2 MUTATIONS IN SUBJECTS WITH LUNG-CARCINOMA IN THE NCI-MAYO LUNG-CANCER STUDY, Laboratory investigation, 74(1), 1996, pp. 946-946
IMMUNOPHENOTYPIC OVERLAP BETWEEN PULMONARY CARCINOID-TUMORS AND METASTATIC BREAST-CARCINOMA
Authors: SCHEMBRIWISMAYER D MYERS J TAZELAAR H LLOYD R
Citation: D. Schembriwismayer et al., IMMUNOPHENOTYPIC OVERLAP BETWEEN PULMONARY CARCINOID-TUMORS AND METASTATIC BREAST-CARCINOMA, Laboratory investigation, 74(1), 1996, pp. 953-953
GENDER COMPARISONS IN HUMAN LUNG-CANCER - ANALYSIS OF P53 MUTATIONS, ANTI-P53 SERUM ANTIBODIES AND C-ERBB-2 EXPRESSION
Authors: GUINEE DG TRAVIS WD TRIVERS GE DEBENEDETTI VMG CAWLEY H WELSH JA BENNETT WP JETT J COLBY TV TAZELAAR H ABBONDANZO SL PAIROLERO P TRASTEK V CAPORASO NE LIOTTA LA HARRIS CC
Citation: Dg. Guinee et al., GENDER COMPARISONS IN HUMAN LUNG-CANCER - ANALYSIS OF P53 MUTATIONS, ANTI-P53 SERUM ANTIBODIES AND C-ERBB-2 EXPRESSION, Carcinogenesis, 16(5), 1995, pp. 993-1002
CORRELATES OF BCL-2 IMMUNOHISTOCHEMICAL STAINING IN A SURGICAL SERIESOF LUNG-CANCER PATIENTS
Authors: FLEMING MV GUINEE DG CHU WS TRAVIS WD BENNETT WP COLBY TV TAZELAAR H ABBONDANZO SL CAPORASO NE JETT J PAIROLERO P TRASTEK V LIOTTA LA HARRIS CC
Citation: Mv. Fleming et al., CORRELATES OF BCL-2 IMMUNOHISTOCHEMICAL STAINING IN A SURGICAL SERIESOF LUNG-CANCER PATIENTS, Laboratory investigation, 72(1), 1995, pp. 148-148
LYMPHOMATOID GRANULOMATOSIS - EVIDENCE OF IMMUNOPHENOTYPIC DIVERSITY AND RELATIONSHIP TO EBSTEIN-BARR VIRUS-INFECTION
Authors: MYERS J KURTIN P KATZENSTEIN AL TAZELAAR H COLBY T STRICKLER J LLOYD R ISAACSON P
Citation: J. Myers et al., LYMPHOMATOID GRANULOMATOSIS - EVIDENCE OF IMMUNOPHENOTYPIC DIVERSITY AND RELATIONSHIP TO EBSTEIN-BARR VIRUS-INFECTION, Laboratory investigation, 72(1), 1995, pp. 150-150
CELLULAR COMPOSITION OF PULMONARY HAMARTOMAS - IMMUNOHISTOCHEMICAL ANALYSIS OF 30 FIBROMYXOID VARIANTS
Authors: PERRY A MYERS J TAZELAAR H GJEVRE J
Citation: A. Perry et al., CELLULAR COMPOSITION OF PULMONARY HAMARTOMAS - IMMUNOHISTOCHEMICAL ANALYSIS OF 30 FIBROMYXOID VARIANTS, Laboratory investigation, 72(1), 1995, pp. 151-151
GSTM1, CYPIA1 AND CYP2E1 GENOTYPES IN SUBJECTS WITH LUNG-CARCINOMA INTHE NCI-MAYO LUNG-CANCER STUDY
Authors: PRZYGODZKI RM GUINEE DG TRAVIS WD KHAN MA JETT J COLBY TV TAZELAAR H BENNETT WP SHIELDS PG PAIROLERO P TRASTEK V CAPORASO NE LIOTTA LB HARRIS CC
Citation: Rm. Przygodzki et al., GSTM1, CYPIA1 AND CYP2E1 GENOTYPES IN SUBJECTS WITH LUNG-CARCINOMA INTHE NCI-MAYO LUNG-CANCER STUDY, Laboratory investigation, 72(1), 1995, pp. 152-152
NEUROENDOCRINE (NE) DIFFERENTIATION CORRELATES WITH SURVIVAL IN CHEMOTHERAPY TREATED NONSMALL CELL LUNG-CANCER (NSCLC)
Authors: SCHLEUSENER J TAZELAAR H JUNG S CERA P MYERS J CREAGAN E GOLDBERG R MARSCHKE R
Citation: J. Schleusener et al., NEUROENDOCRINE (NE) DIFFERENTIATION CORRELATES WITH SURVIVAL IN CHEMOTHERAPY TREATED NONSMALL CELL LUNG-CANCER (NSCLC), Laboratory investigation, 72(1), 1995, pp. 153-153
P53 MUTATIONAL SPECTRUM, IMMUNOHISTOCHEMISTRY, AND SERUM ANTIBODIES IN LUNG-CARCINOMA - ANALYSIS OF 36 FEMALE-PATIENTS
Authors: GUINEE D TRAVIS W TRIVERS G DEBENEDETTI V CAWLEY H WELSH J JETT J COLBY T TAZELAAR H PAIROLERO P BENNETT W TRASTEK V CAPORASO N LIOTTA L HARRIS C
Citation: D. Guinee et al., P53 MUTATIONAL SPECTRUM, IMMUNOHISTOCHEMISTRY, AND SERUM ANTIBODIES IN LUNG-CARCINOMA - ANALYSIS OF 36 FEMALE-PATIENTS, Laboratory investigation, 70(1), 1994, pp. 10000150-10000150
Risultati: 1-22 |